Emcure Pharmaceuticals (India) Price Prediction
| EMCURE Stock | 1,387 13.80 1.01% |
Oversold Vs Overbought
45
Oversold | Overbought |
Quarterly Earnings Growth 0.103 | Wall Street Target Price 1.6 K | Quarterly Revenue Growth 0.166 |
Using Emcure Pharmaceuticals hype-based prediction, you can estimate the value of Emcure Pharmaceuticals from the perspective of Emcure Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Emcure Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Emcure because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Emcure Pharmaceuticals after-hype prediction price | INR 1382.89 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Emcure |
Emcure Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Emcure Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Emcure Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Emcure Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Emcure Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Emcure Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Emcure Pharmaceuticals' historical news coverage. Emcure Pharmaceuticals' after-hype downside and upside margins for the prediction period are 1,381 and 1,525, respectively. We have considered Emcure Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Emcure Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Emcure Pharmaceuticals is based on 3 months time horizon.
Emcure Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Emcure Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Emcure Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Emcure Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.04 | 2.25 | 3.81 | 0.02 | 1 Events / Month | 1 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1,387 | 1,383 | 0.27 |
|
Emcure Pharmaceuticals Hype Timeline
Emcure Pharmaceuticals is currently traded for 1,387on National Stock Exchange of India of India. The entity has historical hype elasticity of -3.81, and average elasticity to hype of competition of -0.02. Emcure is anticipated to decline in value after the next headline, with the price expected to drop to 1382.89. The average volatility of media hype impact on the company price is about 2.36%. The price decline on the next news is expected to be -0.27%, whereas the daily expected return is currently at -0.04%. The volatility of related hype on Emcure Pharmaceuticals is about 371.46%, with the expected price after the next announcement by competition of 1,387. About 87.0% of the company shares are held by company insiders. The company recorded earning per share (EPS) of 26.38. Emcure Pharmaceuticals had not issued any dividends in recent years. Assuming the 90 days trading horizon the next anticipated press release will be very soon. Check out Emcure Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Emcure Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Emcure Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Emcure Pharmaceuticals' future price movements. Getting to know how Emcure Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Emcure Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CALSOFT | California Software | 0.03 | 4 per month | 0.00 | (0.20) | 3.62 | (4.74) | 10.01 | |
| FCSSOFT | FCS Software Solutions | 0.09 | 2 per month | 0.00 | (0.03) | 6.10 | (4.07) | 16.67 | |
| VMART | V Mart Retail Limited | 14.60 | 3 per month | 2.86 | 0.03 | 5.73 | (4.97) | 19.38 | |
| PRAXIS | Praxis Home Retail | 2.13 | 1 per month | 0.00 | (0.11) | 4.37 | (5.01) | 10.00 | |
| ALKALI | Alkali Metals Limited | (5.08) | 2 per month | 0.00 | (0.05) | 3.85 | (3.78) | 9.54 | |
| MUFTI | Credo Brands Marketing | (2.26) | 1 per month | 0.00 | (0.06) | 4.96 | (4.48) | 21.68 | |
| TCI | Transport of | (13.75) | 4 per month | 2.12 | (0) | 5.00 | (3.51) | 13.03 |
Emcure Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Emcure price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Emcure using various technical indicators. When you analyze Emcure charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Emcure Pharmaceuticals Predictive Indicators
The successful prediction of Emcure Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Emcure Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Emcure Pharmaceuticals based on analysis of Emcure Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Emcure Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Emcure Pharmaceuticals's related companies.
Story Coverage note for Emcure Pharmaceuticals
The number of cover stories for Emcure Pharmaceuticals depends on current market conditions and Emcure Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Emcure Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Emcure Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Complementary Tools for Emcure Stock analysis
When running Emcure Pharmaceuticals' price analysis, check to measure Emcure Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emcure Pharmaceuticals is operating at the current time. Most of Emcure Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Emcure Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emcure Pharmaceuticals' price. Additionally, you may evaluate how the addition of Emcure Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |